[Skip to Content]
[Skip to Content Landing]
Views 142
Citations 0
Comment & Response
November 4, 2019

Vital Considerations for Aspirin in Prevention of Preeclampsia, a Multifaceted Pregnancy Disorder—Reply

Author Affiliations
  • 1First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
JAMA Pediatr. Published online November 4, 2019. doi:https://doi.org/10.1001/jamapediatrics.2019.4021

In Reply Our Viewpoint1 summarized animal studies with respect to the association of cyclooxygenase (COX) 2 and prostaglandin-E2 (PGE2) disruption with neurodevelopment, including the use of COX inhibitors such as aspirin or indomethacin.1 Relevant research needs to be introduced in pediatric clinical discussions and warrants future neurobehavioral studies, especially because clinical data will probably lead to (1) treatment of considerably more pregnant women (almost 11% of total) at high risk for preeclampsia with low-dose aspirin (LDA) and (2) increased and prolonged fetal exposure to aspirin.2

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×